Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular Age-related Macular Degeneration (AMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03509623
What this trial is testing

Blood Coagulation Parameters in Patients Receiving Intravitreal Aflibercept for Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
University Hospital of Patras 47
Not applicableStudy completedNCT03324542
What this trial is testing

Real World Outcomes of Intravitreal Anti-vascular Endothelial Growth Factors for Neovascular Age Related Macular Degeneration in Taiwan

Who this might be right for
AMD
Changhua Christian Hospital 63
Large-scale testing (Phase 3)Study completedNCT02307682
What this trial is testing

Efficacy and Safety of RTH258 Versus Aflibercept - Study 1

Who this might be right for
Neovascular Age-Related Macular DegenerationChoroidal Neovascularization
Alcon Research 1,775
Early research (Phase 1)WithdrawnNCT04919096
What this trial is testing

Study of SCB-420 in Subjects With Neovascular Age-related Macular Degeneration

Who this might be right for
Wet Age-related Macular Degeneration
Clover Biopharmaceuticals AUS Pty
Early research (Phase 1)Study completedNCT00765921
What this trial is testing

Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma

Who this might be right for
Choroidal Melanoma
Massachusetts Eye and Ear Infirmary 40
Not applicableStudy completedNCT01650948
What this trial is testing

Genetic Load and Phenotype in Aggressive AMD

Who this might be right for
Age-related Macular Degeneration
Sequenom, Inc. 100
Not applicableStudy completedNCT04641234
What this trial is testing

A Study Reviewing Medical Records to Learn More About Treat-and-extend With Eylea in Patients With Neovascular Age-related Macular Degeneration (nAMD).

Who this might be right for
Neovascular Age-related Macular Degeneration
Bayer 330
Not applicableStudy completedNCT02569892
What this trial is testing

Non-Damaging Photothermal Therapy of Non-exudative Age Related Macular Degeneration

Who this might be right for
Macular DegenerationRetinal Drusen
Stanford University 19
Testing effectiveness (Phase 2)Study completedNCT04331730
What this trial is testing

Assess the Efficacy and Safety of AKST4290 With Aflibercept in Patients With Newly Diagnosed nAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Alkahest, Inc. 107
Not applicableUnknownNCT02988895
What this trial is testing

Episcleral Brachytherapy for the Treatment of Wet AMD

Who this might be right for
Macular Degeneration, Choroidal Neovascularization
Salutaris Medical Devices, Inc. 11
Large-scale testing (Phase 3)Not Yet RecruitingNCT07129239
What this trial is testing

High Dose (HD) Aflibercept Switch in Neovascular Age-related Macular Degeneration (nAMD): to Load or Maintain (HEIRLOOM)

Who this might be right for
Wet Age-related Macular Degeneration (wAMD)
Clinique de Retine de l'est 180
Testing effectiveness (Phase 2)Study completedNCT02914639
What this trial is testing

Safety and Exploratory Efficacy Study of SF0166 in the Treatment of Neovascular Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
OcuTerra Therapeutics, Inc. 44
Not applicableLooking for participantsNCT07446582
What this trial is testing

Real-World Evaluation of AI Enabled Multi-Spectral Imaging (MSI) for AMD Biomarker Detection

Who this might be right for
Age-Related (Dry) Macular Degeneration
AI-Spectral 1,000
Testing effectiveness (Phase 2)Study completedNCT03038880
What this trial is testing

Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration

Who this might be right for
Neovascularization, ChoroidalMacular Degeneration, Age-Related
Hoffmann-La Roche 76
Testing effectiveness (Phase 2)Study completedNCT03953079
What this trial is testing

A Depot Formulation of Sunitinib Malate (GB-102) Compared to Aflibercept in Subjects With Wet AMD

Who this might be right for
Neovascular Age-Related Macular Degeneration
Graybug Vision 56
Not applicableStudy completedNCT01880788
What this trial is testing

Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD

Who this might be right for
Age Related Macular DegenerationChoroidal NeovascularizationCentral Serous Chorioretinopathy
Sequenom, Inc. 152
Not applicableStudy completedNCT00656903
What this trial is testing

High Speed Indocyanine Green Angiography Findings in Ranibizumab Treatment for Wet Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 75
Large-scale testing (Phase 3)Study completedNCT04516278
What this trial is testing

A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders

Who this might be right for
Age-related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration+2 more
Outlook Therapeutics, Inc. 197
Large-scale testing (Phase 3)Ended earlyNCT03630952
What this trial is testing

Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-2)

Who this might be right for
Neovascular Age-related Macular Degeneration
Chengdu Kanghong Biotech Co., Ltd. 1,157
Not applicableActive Not RecruitingNCT06680817
What this trial is testing

A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Hoffmann-La Roche 850
Next Page